Publications

5674 Results

Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803 [PMID21849660;PMC3196479]

Authors
K Ng;S Ogino;JA Meyerhardt;AT Chan;D Niedzwiecki;D Hollis;LB Saltz;RJ Mayer;AB Benson;P Schaefer;R Whittom;A Hantel;RM Goldberg;M Bertagnolli;AP Venook;C Fuchs
Journal / Conference
Journal of the National Cancer Institute 103(20):1540-1551;
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT)

Authors
EA Klein;IM Thompson;C Tangen;J Crowley;MS Lucia;P Goodman;L Minasian;L Ford;H Parnes;JM Gaziano;D Karp;M Lieber;P Walther;L Klotz;JK Parsons;J Chin;A Darke;S Lippman;G Goodman;F Meyskens;LH Baker
Journal / Conference
Journal of the American Medical Association 306(14):1549-1556;
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID21990298
PMC
PMC4169010
Study Number(s)
S0000

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial PMID21771722; PMC3179424

Authors
L Tang;S Yao;C Tangen;Y Wu;A Kristal;E Platz;M Neuhouser;F Stanczyk;J Reichardt;R Santella;A Hsing;A Hoque;S Lippman;IM Thompson;C Ambrosone
Journal / Conference
Carcinogenesis 32(10):1500-1506
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a Children's Oncology Group and Southwest Oncology Group Study [PMID21873548; PMC3208275]

Authors
P Ho;K Kopecky;T Alonzo;R Gerbing;K Miller;J Kuhn;R Ries;S Raimondi;B Hirsch;V Oehler;C Hurwitz;J Franklin;A Gamis;S Petersdorf;J Anderson;J Godwin;G Reaman;C Willman;I Bernstein;J Radich;F Appelbaum;D Stirewalt
Journal / Conference
Blood 118(17):4561-4566
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031, SWOG-9500

Incidence of therapy-related myeloid neoplasia after initial for CLL with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US intergroup study E2997 [PMID21803850; PMC3186330]

Authors
MR Smith;D Neuberg;IW Flynn;MR Grever;HM Lazarus;JM Rowe;G Dewald;JM Bennett;E Paietta;JC Byrd;MA Hussein;FR Appelbaum;RA Larson;MR Litzow;MS Tallman
Journal / Conference
Blood 118(13):3525-3527
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
E2997

p53 expression in node-positive breast cancer patients: results from the cancer and leukemia group B 9344 trial (159905) [PMID21693655; PMC3149770]

Authors
JF Lara;LG Dressler;G Broadwater;IJ Bleiweiss;S Edgerton;D Cowan;L Goldstein;S Martino;J Ingle;IC Henderson;L Norton;E Winer;C Hudis;MJ Ellis;DA Berry;DF Hayes
Journal / Conference
Clinical Cancer Research 17(15):5170-5178
Year
2011
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

Benchmarks for evaluating phase II clinical trials in stage IV melanoma: the recent SWOG experience

Authors
V Sondak;M Othus;L Flaherty;B Redman;J Moon;K Margolin;C Lao;W Carson;A Ribas
Journal / Conference
International Melanoma Congress, abstract 50; 8th Annual Meeting, Nov 9-11, 2011, Tampa, Fl; oral presentation
Year
2011
Research Committee(s)
Melanoma
Study Number(s)
S0026, S0438, S0508, S0512, S0826

SWOG S0120 observational trial for MGUS and asymptomatic multiple myeloma (AMM): imaging predictors of progression for patients treated at UAMS

Authors
C Heuck;R Sexton;M Dhodapkar;Q Zhang;S Usmani;B Nair;F van Rhee;A Hoering;J Crowley;J Shaughnessy;R Orlowski;B Barlogie
Journal / Conference
Blood 118(21):abst 3955; American Society of Hematolgy, poster presentation
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
S0120

A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK intercontinental trial CRUKE/01/013

Authors
JM Crook;CJ O'Callaghan;K Ding;G Duncan;D Dearnaley;C Higano;E Horwitz;E Frymire;S Malone;J Chin;A Nabid;P Warde;T Corbett;S Angyalfi;SL Goldenberg;M Gospodarowicz;J Loque;P Shellhammer;F Saad;L Klotz
Journal / Conference
Journal of Clinical Oncology 29:(suppl; abstr 4514); ASCO oral presentation
Year
2011
Research Committee(s)
Genitourinary
Study Number(s)
JPR7

Systemic evaluation of the impact of disease progression (DP) date determination on progression-free survival (PFS) in advanced lung cancer: a joint North Central Cancer Treatment Group (NCCTG) and Southwest Oncology Group (SWOG) investigation

Authors
SJ Mandrekar;Y Qi;K Allen-Ziegler;SL Hillman;M Redman;SE Schild;D Gandara;A Adjei
Journal / Conference
Journal of Clinical Oncology 29:(suppl 4: abstr 2); ASCO oral presentation
Year
2011
Research Committee(s)
Lung